These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

241 related items for PubMed ID: 2154925

  • 1. Rhesus Rotavirus candidate vaccine. Clinical trial in children vaccinated between 2 and 5 months of age.
    Vesikari T, Rautanen T, Varis T, Beards GM, Kapikian AZ.
    Am J Dis Child; 1990 Mar; 144(3):285-9. PubMed ID: 2154925
    [Abstract] [Full Text] [Related]

  • 2. Efficacy of the rhesus rotavirus-based quadrivalent vaccine in infants and young children in Venezuela.
    Pérez-Schael I, Guntiñas MJ, Pérez M, Pagone V, Rojas AM, González R, Cunto W, Hoshino Y, Kapikian AZ.
    N Engl J Med; 1997 Oct 23; 337(17):1181-7. PubMed ID: 9337376
    [Abstract] [Full Text] [Related]

  • 3. Immunogenicity, safety and efficacy of tetravalent rhesus-human, reassortant rotavirus vaccine in Belém, Brazil.
    Linhares AC, Gabbay YB, Mascarenhas JD, de Freitas RB, Oliveira CS, Bellesi N, Monteiro TA, Lins-Lainson Z, Ramos FL, Valente SA.
    Bull World Health Organ; 1996 Oct 23; 74(5):491-500. PubMed ID: 9002329
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Evaluation of RIX4414, a live, attenuated rotavirus vaccine, in a randomized, double-blind, placebo-controlled phase 2 trial involving 2464 Singaporean infants.
    Phua KB, Quak SH, Lee BW, Emmanuel SC, Goh P, Han HH, De Vos B, Bock HL.
    J Infect Dis; 2005 Sep 01; 192 Suppl 1():S6-S16. PubMed ID: 16088807
    [Abstract] [Full Text] [Related]

  • 6. Neonatal administration of rhesus rotavirus tetravalent vaccine.
    Vesikari T, Karvonen A, Forrest BD, Hoshino Y, Chanock RM, Kapikian AZ.
    Pediatr Infect Dis J; 2006 Feb 01; 25(2):118-22. PubMed ID: 16462287
    [Abstract] [Full Text] [Related]

  • 7. Protection of infants against rotavirus diarrhoea by RIT 4237 attenuated bovine rotavirus strain vaccine.
    Vesikari T, Isolauri E, D'Hondt E, Delem A, André FE, Zissis G.
    Lancet; 1984 May 05; 1(8384):977-81. PubMed ID: 6143964
    [Abstract] [Full Text] [Related]

  • 8. Comparison of immunogenicity and efficacy of rhesus rotavirus reassortant vaccines in breastfed and nonbreastfed children. US Rotavirus Vaccine Efficacy Group.
    Rennels MB, Wasserman SS, Glass RI, Keane VA.
    Pediatrics; 1995 Dec 05; 96(6):1132-6. PubMed ID: 7491235
    [Abstract] [Full Text] [Related]

  • 9. Evaluation of rhesus rotavirus monovalent and tetravalent reassortant vaccines in US children. US Rotavirus Vaccine Efficacy Group.
    Bernstein DI, Glass RI, Rodgers G, Davidson BL, Sack DA.
    JAMA; 1995 Apr 19; 273(15):1191-6. PubMed ID: 7707626
    [Abstract] [Full Text] [Related]

  • 10. Rotavirus vaccines: new drug. Rotavirus infection: one case of severe diarrhoea prevented per 100 vaccinated infants.
    Prescrire Int; 2007 Feb 19; 16(87):3-6. PubMed ID: 17323513
    [Abstract] [Full Text] [Related]

  • 11. Randomised placebo-controlled trial of rhesus-human reassortant rotavirus vaccine for prevention of severe rotavirus gastroenteritis.
    Joensuu J, Koskenniemi E, Pang XL, Vesikari T.
    Lancet; 1997 Oct 25; 350(9086):1205-9. PubMed ID: 9652561
    [Abstract] [Full Text] [Related]

  • 12. Clinical and immunological studies of rotavirus vaccines.
    Vesikari T.
    Southeast Asian J Trop Med Public Health; 1988 Sep 25; 19(3):437-47. PubMed ID: 2851185
    [Abstract] [Full Text] [Related]

  • 13. Live attenuated human rotavirus vaccine, Rotarix.
    Bernstein DI.
    Semin Pediatr Infect Dis; 2006 Oct 25; 17(4):188-94. PubMed ID: 17055369
    [Abstract] [Full Text] [Related]

  • 14. Dose response and efficacy of a live, attenuated human rotavirus vaccine in Mexican infants.
    Ruiz-Palacios GM, Guerrero ML, Bautista-Márquez A, Ortega-Gallegos H, Tuz-Dzib F, Reyes-González L, Rosales-Pedraza G, Martínez-López J, Castañón-Acosta E, Cervantes Y, Costa-Clemens S, DeVos B.
    Pediatrics; 2007 Aug 25; 120(2):e253-61. PubMed ID: 17606534
    [Abstract] [Full Text] [Related]

  • 15. A dose-escalation safety and immunogenicity study of live attenuated oral rotavirus vaccine 116E in infants: a randomized, double-blind, placebo-controlled trial.
    Bhandari N, Sharma P, Taneja S, Kumar T, Rongsen-Chandola T, Appaiahgari MB, Mishra A, Singh S, Vrati S, Rotavirus Vaccine Development Group.
    J Infect Dis; 2009 Aug 01; 200(3):421-9. PubMed ID: 19545211
    [Abstract] [Full Text] [Related]

  • 16. Safety, efficacy, and immunogenicity of a live, quadrivalent human-bovine reassortant rotavirus vaccine in healthy infants.
    Clark HF, Bernstein DI, Dennehy PH, Offit P, Pichichero M, Treanor J, Ward RL, Krah DL, Shaw A, Dallas MJ, Laura D, Eiden JJ, Ivanoff N, Kaplan KM, Heaton P.
    J Pediatr; 2004 Feb 01; 144(2):184-90. PubMed ID: 14760258
    [Abstract] [Full Text] [Related]

  • 17. The pentavalent rotavirus vaccine, RotaTeq.
    Matson DO.
    Semin Pediatr Infect Dis; 2006 Oct 01; 17(4):195-9. PubMed ID: 17055370
    [Abstract] [Full Text] [Related]

  • 18. Safety and efficacy of high-dose rhesus-human reassortant rotavirus vaccines--report of the National Multicenter Trial. United States Rotavirus Vaccine Efficacy Group.
    Rennels MB, Glass RI, Dennehy PH, Bernstein DI, Pichichero ME, Zito ET, Mack ME, Davidson BL, Kapikian AZ.
    Pediatrics; 1996 Jan 01; 97(1):7-13. PubMed ID: 8545227
    [Abstract] [Full Text] [Related]

  • 19. [Oral vaccination with live attenuated rotavirus].
    Escobar Castro H, Perdomo Giraldi M, Tamáriz-Martel Moreno A, Suárez Cortina L.
    An Esp Pediatr; 1988 Jun 01; 28(6):527-9. PubMed ID: 2848432
    [Abstract] [Full Text] [Related]

  • 20. Response to RIT 4237 oral rotavirus vaccine in breast-fed and formula-fed infants.
    Zoppi G, Ferrarini G, Rigolin F, Bogaerts H, André FE.
    Helv Paediatr Acta; 1986 Aug 01; 41(3):203-8. PubMed ID: 3019954
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.